Mid-Atlantic Section of the American Urological Association
Home | About Us | Contact Us   
  Home
  Members
    Members Only Area
    Member Directory
    Join the MA-AUA
  Annual Meeting
  Board of Directors
  Committees
  Careers
  Newsletters
  Visit the AUA
  Advocacy Efforts
  MAAUA Research
  Scholarship
Didusch Museum
About the Mid-Atlantic Section of the American Urological Association (MAAUA)

 
  Members Only
  Username
 
  Password
 
   Forgot Password?

 

Back to Scientific Program
Back to Annual Meeting
A Critical Analysis Of the Interpretation Of Biochemical Recurrence In Surgically Treated Patients Using the Revised ASTRO Criterion (“Nadir + 2”)
Matthew E. Nielsen, Danil V. Makarov, Elizabeth Humphreys, Leslie Mangold, Alan W. Partin, Patrick C. Walsh
Johns Hopkins, Baltimore, MD

Introduction: A combined ASTRO/RTOG consensus conference was convened in 2005 to address shortcomings of the 1997 consensus definition of biochemical failure after radiation therapy for prostate cancer. The updated recommendation is that failure after radiation be defined as a PSA ≥ absolute nadir PSA plus 2 ng/ml. We evaluated the effects of this definition on the interpretation of failure when applied to radical prostatectomy.
Methods: We reviewed data from 2,570 men who underwent radical prostatectomy from 1985 to 2004. Biochemical failure was defined as any measurable PSA ≥0.2 ng/ml. We evaluated how the nadir+2 definition affected the failure rate when applied to this series.
Results: The actuarial 5-, 10- and 15-year biochemical recurrence-free survival probabilities with failure defined as PSA>0.2 ng/ml and PSA≥2 ng/ml were 88.6%, 81.2% and 78.1%, and 94.6%, 89.4%, and 84.3%, respectively (p<0.0001). Median time to biochemical progression was 2.8 years for the >0.2 ng/ml definition and 7.9 years for the ≥ 2 ng/ml definition. The nadir+2 definition systematically overestimated cure, even after stratifying patients into standard prognostic risk groups, especially in men who developed local recurrence.
Conclusions: When applied to a mature series of surgically treated patients with localized prostate cancer, the ASTRO “nadir+2”definition of biochemical failure results in a systematic overestimation of cure, relative to the standard surgical definition. This was particularly evident for men who developed local progression. Caution must be exercised when comparing outcomes between series due to inherent differences in the definition of biochemical failure.


Back to Scientific Program
Back to Annual Meeting

 

Copyright © 2012 Mid-Atlantic Section of the American Urological Association. All Rights Reserved.
Read Privacy Policy.